I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Defining Unmet Need Following Lenalidomide Refractoriness: ..:
Catherine S. Y. Lecat
;
Jessica B. Taube
;
William Wilson
...
https://www.frontiersin.org/articles/10.3389/fonc.2021.703233/full. , 2021
Link:
https://doi.org/10.3389/fonc.2021.703233
RT Journal T1
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:824d4c0c5b7c4fb48057514e0769e341&Exemplar=1&LAN=DE A1 Catherine S. Y. Lecat A1 Jessica B. Taube A1 William Wilson A1 Jonathan Carmichael A1 Christopher Parrish A1 Gabriel Wallis A1 Charalampia Kyriakou A1 Lydia Lee A1 Shameem Mahmood A1 Xenofon Papanikolaou A1 Neil K. Rabin A1 Jonathan Sive A1 Ashutosh D. Wechalekar A1 Kwee Yong A1 Gordon Cook A1 Rakesh Popat PB Frontiers Media S.A. YR 2021 K1 multiple myeloma K1 relapsed myeloma K1 lenalidomide K1 real-world data K1 Revlimid K1 survival outcomes K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2021.703233/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2021.703233 DO https://doi.org/10.3389/fonc.2021.703233 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)